{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:03:53Z","timestamp":1784315033261,"version":"3.55.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100024151","name":"CropLife Europe","doi-asserted-by":"publisher","award":["CropLife Europe"],"award-info":[{"award-number":["CropLife Europe"]}],"id":[{"id":"10.13039\/501100024151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00204-026-04411-1","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T18:59:59Z","timestamp":1778007599000},"page":"3759-3775","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The use of cultured human hepatocytes as a test system to evaluate cell proliferation as a key event in nongenotoxic carcinogenesis"],"prefix":"10.1007","volume":"100","author":[{"given":"David E.","family":"Cowie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel M.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Goettel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Nadzialek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uku","family":"Rooni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike E.","family":"Schutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Tinwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Turiccki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7001-1659","authenticated-orcid":false,"given":"Christian","family":"Strupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"issue":"4972","key":"4411_CR1","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1126\/science.2136249","volume":"249","author":"BN Ames","year":"1990","unstructured":"Ames BN, Gold LS (1990) Too many rodent carcinogens: mitogenesis increases mutagenesis. Science 249(4972):970\u2013971. https:\/\/doi.org\/10.1126\/science.2136249","journal-title":"Science"},{"issue":"1","key":"4411_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3109\/10408444.2013.835785","volume":"44","author":"ME Andersen","year":"2014","unstructured":"Andersen ME, Preston RJ, Maier A, Willis AM, Patterson J (2014) Dose-response approaches for nuclear receptor-mediated modes of action for liver carcinogenicity: results of a workshop. Crit Rev Toxicol 44(1):50\u201363. https:\/\/doi.org\/10.3109\/10408444.2013.835785","journal-title":"Crit Rev Toxicol"},{"issue":"4","key":"4411_CR3","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1039\/c7tx00283a","volume":"7","author":"C Berry","year":"2018","unstructured":"Berry C (2018) The failure of rodent carcinogenesis as a model for man. Toxicol Res (Camb) 7(4):553\u2013557. https:\/\/doi.org\/10.1039\/c7tx00283a","journal-title":"Toxicol Res (Camb)"},{"issue":"9","key":"4411_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045259","volume":"7","author":"S Bonovas","year":"2012","unstructured":"Bonovas S, Nikolopoulos GK, Bagos PG (2012) Use of fibrates and cancer risk: a systematic review and meta-analysis of 17 long-term randomized placebo-controlled trials. PLoS ONE 7(9):e45259. https:\/\/doi.org\/10.1371\/journal.pone.0045259","journal-title":"PLoS ONE"},{"issue":"10","key":"4411_CR5","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1080\/10408440600977677","volume":"36","author":"AR Boobis","year":"2006","unstructured":"Boobis AR, Cohen SM, Dellarco V, McGregor D, Meek ME, Vickers C, Willcocks D, Farland W (2006) IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit Rev Toxicol 36(10):781\u2013792. https:\/\/doi.org\/10.1080\/10408440600977677","journal-title":"Crit Rev Toxicol"},{"key":"4411_CR6","doi-asserted-by":"publisher","unstructured":"Capel\u00f4a T, Prieto P, Berggren E, Corvi R (2024) The usefulness of in vitro mechanistic information in regulatory dossiers \u2013 The case of the CAR MoA in carcinogenicity assessment, https:\/\/doi.org\/10.2760\/7961005. Publications Office of the European Union","DOI":"10.2760\/7961005"},{"issue":"Pt B","key":"4411_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2019.105256","volume":"133","author":"E Carnesecchi","year":"2019","unstructured":"Carnesecchi E, Svendsen C, Lasagni S, Grech A, Quignot N, Amzal B, Toma C, Tosi S, Rortais A, Cortinas-Abrahantes J, Capri E, Kramer N, Benfenati E, Spurgeon D, Guillot G, Dorne JLCM (2019) Investigating combined toxicity of binary mixtures in bees: meta-analysis of laboratory tests, modelling, mechanistic basis and implications for risk assessment. Environ Int 133(Pt B):105256. https:\/\/doi.org\/10.1016\/j.envint.2019.105256","journal-title":"Environ Int"},{"issue":"2","key":"4411_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/toxsci\/kfh159","volume":"80","author":"SM Cohen","year":"2004","unstructured":"Cohen SM (2004) Human carcinogenic risk evaluation: an alternative approach to the two-year rodent bioassay. Toxicol Sci 80(2):225\u2013229. https:\/\/doi.org\/10.1093\/toxsci\/kfh159","journal-title":"Toxicol Sci"},{"issue":"3","key":"4411_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1177\/0192623310363813","volume":"38","author":"SM Cohen","year":"2010","unstructured":"Cohen SM (2010) Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary. Toxicol Pathol 38(3):487\u2013501. https:\/\/doi.org\/10.1177\/0192623310363813","journal-title":"Toxicol Pathol"},{"key":"4411_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cotox.2017.04.002","volume":"3","author":"SM Cohen","year":"2017","unstructured":"Cohen SM (2017) The relevance of experimental carcinogenicity studies to human safety. Curr Opin Toxicol 3:6\u201311. https:\/\/doi.org\/10.1016\/j.cotox.2017.04.002","journal-title":"Curr Opin Toxicol"},{"key":"4411_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1394584","volume":"14","author":"SM Cohen","year":"2024","unstructured":"Cohen SM (2024) Cell proliferation and carcinogenesis: an approach to screening for potential human carcinogens. Front Oncol 14:1394584. https:\/\/doi.org\/10.3389\/fonc.2024.1394584","journal-title":"Front Oncol"},{"issue":"suppl 1","key":"4411_CR12","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1093\/toxsci\/kfq365","volume":"120","author":"SM Cohen","year":"2011","unstructured":"Cohen SM, Arnold LL (2011) Chemical carcinogenesis. Toxicol Sci 120(suppl 1):S76\u2013S92. https:\/\/doi.org\/10.1093\/toxsci\/kfq365","journal-title":"Toxicol Sci"},{"issue":"4","key":"4411_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1293\/tox.2016-0036","volume":"29","author":"SM Cohen","year":"2016","unstructured":"Cohen SM, Arnold LL (2016) Critical role of toxicologic pathology in a short-term screen for carcinogenicity. J Toxicol Pathol 29(4):215\u2013227. https:\/\/doi.org\/10.1293\/tox.2016-0036","journal-title":"J Toxicol Pathol"},{"issue":"2","key":"4411_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/toxsci\/kfh073","volume":"78","author":"SM Cohen","year":"2004","unstructured":"Cohen SM, Klaunig J, Meek ME, Hill RN, Pastoor T, Lehman-McKeeman L, Bucher J, Longfellow DG, Seed J, Dellarco V, Patton D (2004) Evaluating the human relevance of chemically induced animal tumors. Toxicol Sci 78(2):181\u2013186. https:\/\/doi.org\/10.1093\/toxsci\/kfh073","journal-title":"Toxicol Sci"},{"key":"4411_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.yrtph.2019.01.017","volume":"103","author":"SM Cohen","year":"2019","unstructured":"Cohen SM, Boobis AR, Dellarco VL, Doe JE, Fenner-Crisp PA, Moretto A, Pastoor TP, Schoeny RS, Seed JG, Wolf DC (2019) Chemical carcinogenicity revisited 3: risk assessment of carcinogenic potential based on the current state of knowledge of carcinogenesis in humans. Regul Toxicol Pharmacol 103:100\u2013105. https:\/\/doi.org\/10.1016\/j.yrtph.2019.01.017","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1","key":"4411_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10408444.2013.835784","volume":"44","author":"JC Corton","year":"2014","unstructured":"Corton JC, Cunningham ML, Hummer BT, Lau C, Meek B, Peters JM, Popp JA, Rhomberg L, Seed J, Klaunig JE (2014) Mode of action framework analysis for receptor-mediated toxicity: the peroxisome proliferator-activated receptor alpha (PPARalpha) as a case study. Crit Rev Toxicol 44(1):1\u201349. https:\/\/doi.org\/10.3109\/10408444.2013.835784","journal-title":"Crit Rev Toxicol"},{"issue":"1","key":"4411_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00204-017-2094-7","volume":"92","author":"JC Corton","year":"2018","unstructured":"Corton JC, Peters JM, Klaunig JE (2018) The PPARalpha-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions. Arch Toxicol 92(1):83\u2013119. https:\/\/doi.org\/10.1007\/s00204-017-2094-7","journal-title":"Arch Toxicol"},{"key":"4411_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2021.106760","volume":"156","author":"K Darney","year":"2021","unstructured":"Darney K, Lautz LS, B\u00e9chaux C, Wiecek W, Testai E, Amzal B, Dorne JLCM (2021) Human variability in polymorphic CYP2D6 metabolism: implications for the risk assessment of chemicals in food and emerging designer drugs. Environ Int 156:106760. https:\/\/doi.org\/10.1016\/j.envint.2021.106760","journal-title":"Environ Int"},{"key":"4411_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.yrtph.2019.01.024","volume":"103","author":"JE Doe","year":"2019","unstructured":"Doe JE, Boobis AR, Dellarco V, Fenner-Crisp PA, Moretto A, Pastoor TP, Schoeny RS, Seed JG, Wolf DC (2019) Chemical carcinogenicity revisited 2: current knowledge of carcinogenesis shows that categorization as a carcinogen or non-carcinogen is not scientifically credible. Regul Toxicol Pharmacol 103:124\u2013129. https:\/\/doi.org\/10.1016\/j.yrtph.2019.01.024","journal-title":"Regul Toxicol Pharmacol"},{"issue":"9","key":"4411_CR20","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1007\/s00204-022-03324-z","volume":"96","author":"JE Doe","year":"2022","unstructured":"Doe JE, Boobis AR, Cohen SM, Dellarco VL, Fenner-Crisp PA, Moretto A, Pastoor TP, Schoney RS, Seed JG, Wolf DC (2022) A new approach to the classification of carcinogenicity. Arch Toxicol 96(9):2419\u20132428. https:\/\/doi.org\/10.1007\/s00204-022-03324-z","journal-title":"Arch Toxicol"},{"issue":"1","key":"4411_CR21","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/j.1749-6632.1996.tb18649.x","volume":"804","author":"CR Elcombe","year":"1996","unstructured":"Elcombe CR, Bell DR, Elias E, Hasmall SC, Plant NJ (1996) Peroxisome proliferators: species differences in response of primary hepatocyte cultures. Ann N Y Acad Sci 804(1):628\u2013635. https:\/\/doi.org\/10.1111\/j.1749-6632.1996.tb18649.x","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"4411_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3109\/10408444.2013.835786","volume":"44","author":"CR Elcombe","year":"2014","unstructured":"Elcombe CR, Peffer RC, Wolf DC, Bailey J, Bars R, Bell D, Cattley RC, Ferguson SS, Geter D, Goetz A, Goodman JI, Hester S, Jacobs A, Omiecinski CJ, Schoeny R, Xie W, Lake BG (2014) Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: a case study with phenobarbital as a model constitutive androstane receptor (CAR) activator. Crit Rev Toxicol 44(1):64\u201382. https:\/\/doi.org\/10.3109\/10408444.2013.835786","journal-title":"Crit Rev Toxicol"},{"key":"4411_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2025.102130","volume":"15","author":"M Elcombe","year":"2025","unstructured":"Elcombe M, Wallace S, Plummer S (2025) Nucleophosmin 1 induction is an early event in a phenobarbital induced proliferation response in rat but not human liver 3D microtissues. Toxicol Rep 15:102130. https:\/\/doi.org\/10.1016\/j.toxrep.2025.102130","journal-title":"Toxicol Rep"},{"issue":"9","key":"4411_CR24","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/ijc.24545","volume":"125","author":"GD Friedman","year":"2009","unstructured":"Friedman GD, Jiang S-F, Udaltsova N, Quesenberry CP, Chan J, Habel LA (2009) Epidemiologic evaluation of pharmaceuticals with limited evidence of carcinogenicity. Int J Cancer 125(9):2173\u20132178. https:\/\/doi.org\/10.1002\/ijc.24545","journal-title":"Int J Cancer"},{"issue":"8","key":"4411_CR25","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00204-013-1078-5","volume":"87","author":"P Godoy","year":"2013","unstructured":"Godoy P, Hewitt NJ, Albrecht U, Andersen ME, Ansari N, Bhattacharya S et al (2013) Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 87(8):1315\u20131530. https:\/\/doi.org\/10.1007\/s00204-013-1078-5","journal-title":"Arch Toxicol"},{"key":"4411_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2024.153828","volume":"505","author":"M Goettel","year":"2024","unstructured":"Goettel M, Werner C, Honarvar N, Gr\u00f6ters S, Fegert I, Haines C, Chatham LR, Vardy A, Lake BG (2024) Mode of action analysis for fluxapyroxad-induced rat liver tumour formation: evidence for activation of the constitutive androstane receptor and assessment of human relevance. Toxicology 505:153828. https:\/\/doi.org\/10.1016\/j.tox.2024.153828","journal-title":"Toxicology"},{"issue":"6","key":"4411_CR27","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1080\/019262301753385979","volume":"29","author":"LS Gold","year":"2001","unstructured":"Gold LS, Manley NB, Slone TH, Ward JM (2001) Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys. Toxicol Pathol 29(6):639\u2013652. https:\/\/doi.org\/10.1080\/019262301753385979","journal-title":"Toxicol Pathol"},{"issue":"1","key":"4411_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1006\/taap.1999.8737","volume":"160","author":"V Goll","year":"1999","unstructured":"Goll V, Alexandre E, Viollon-Abadie C, Nicod L, Jaeck D, Richert L (1999) Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures. Toxicol Appl Pharmacol 160(1):21\u201332. https:\/\/doi.org\/10.1006\/taap.1999.8737","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"4411_CR29","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1039\/c8tx00004b","volume":"7","author":"JI Goodman","year":"2018","unstructured":"Goodman JI (2018) Goodbye to the bioassay. Toxicol Res 7(4):558\u2013564. https:\/\/doi.org\/10.1039\/c8tx00004b","journal-title":"Toxicol Res"},{"key":"4411_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.tox.2018.02.001","volume":"396\u2013397","author":"C Haines","year":"2018","unstructured":"Haines C, Elcombe BM, Chatham LR, Vardy A, Higgins LG, Elcombe CR, Lake BG (2018) Comparison of the effects of sodium phenobarbital in wild type and humanized constitutive androstane receptor (CAR)\/pregnane X receptor (PXR) mice and in cultured mouse, rat and human hepatocytes. Toxicology 396\u2013397:23\u201332. https:\/\/doi.org\/10.1016\/j.tox.2018.02.001","journal-title":"Toxicology"},{"issue":"8","key":"4411_CR31","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s002040050634","volume":"73","author":"SC Hasmall","year":"1999","unstructured":"Hasmall SC, James NH, Macdonald N, West D, Chevalier S, Cosulich SC, Roberts RA (1999) Suppression of apoptosis and induction of DNA synthesis in vitro by the phthalate plasticizers monoethylhexylphthalate (MEHP) and diisononylphthalate (DINP): a comparison of rat and human hepatocytes in vitro. Arch Toxicol 73(8):451\u2013456. https:\/\/doi.org\/10.1007\/s002040050634","journal-title":"Arch Toxicol"},{"issue":"2","key":"4411_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s002040050657","volume":"74","author":"SC Hasmall","year":"2000","unstructured":"Hasmall SC, James NH, Macdonald N, Soames AR, Roberts RA (2000) Species differences in response to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated gene expression. Arch Toxicol 74(2):85\u201391. https:\/\/doi.org\/10.1007\/s002040050657","journal-title":"Arch Toxicol"},{"issue":"9","key":"4411_CR33","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1080\/10408444.2020.1841732","volume":"50","author":"H Heusinkveld","year":"2020","unstructured":"Heusinkveld H, Braakhuis H, Gommans R, Botham P, Corvaro M, van der Laan JW, Lewis D, Madia F, Manov I, Schorsch F, Wolterink G, Woutersen R, Corvi R, Mehta J, Luijten M (2020) Towards a mechanism-based approach for the prediction of nongenotoxic carcinogenic potential of agrochemicals. Crit Rev Toxicol 50(9):725\u2013739. https:\/\/doi.org\/10.1080\/10408444.2020.1841732","journal-title":"Crit Rev Toxicol"},{"key":"4411_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-1-4939-2074-7_2","volume-title":"Protocols in in vitro hepatocyte research","author":"NJ Hewitt","year":"2015","unstructured":"Hewitt NJ, Li AP (2015) Cryopreservation of hepatocytes. In: Vinken M, Rogiers V (eds) Protocols in in vitro hepatocyte research. Springer New York, New York, NY, pp 13\u201326. https:\/\/doi.org\/10.1007\/978-1-4939-2074-7_2"},{"issue":"1","key":"4411_CR35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/03602530601093489","volume":"39","author":"NJ Hewitt","year":"2007","unstructured":"Hewitt NJ, G\u00f3mez Lech\u00f3n MJ, Houston JB, Hallifax D, Brown HS, Maurel P, Kenna JG, Gustavsson L, Lohmann C, Skonberg C, Guillouzo A, Tuschi G, Li AP, LeCluyse E, Groothuis GMM, Hengstler JG (2007a) Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab Rev 39(1):159\u2013234. https:\/\/doi.org\/10.1080\/03602530601093489","journal-title":"Drug Metab Rev"},{"issue":"10\u201311","key":"4411_CR36","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1080\/00498250701534893","volume":"37","author":"NJ Hewitt","year":"2007","unstructured":"Hewitt NJ, Lecluyse EL, Ferguson SS (2007b) Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro\u2013in vivo correlations. Xenobiotica 37(10\u201311):1196\u20131224. https:\/\/doi.org\/10.1080\/00498250701534893","journal-title":"Xenobiotica"},{"key":"4411_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2022.105301","volume":"137","author":"GM Hilton","year":"2023","unstructured":"Hilton GM, Corvi R, Luijten M, Mehta J, Wolf DC (2023) Towards chieving a modern science-based paradigm for agrochecmical carcinogenicity assessment. Regul Toxicol Pharmacol 137:105301. https:\/\/doi.org\/10.1016\/j.yrtph.2022.105301","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1","key":"4411_CR38","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.tox.2009.01.007","volume":"258","author":"Y Hirose","year":"2009","unstructured":"Hirose Y, Nagahori H, Yamada T, Deguchi Y, Tomigahara Y, Nishioka K, Uwagawa S, Kawamura S, Isobe N, Lake BG, Okuno Y (2009) Comparison of the effects of the synthetic pyrethroid Metofluthrin and phenobarbital on CYP2B form induction and replicative DNA synthesis in cultured rat and human hepatocytes. Toxicology 258(1):64\u201369. https:\/\/doi.org\/10.1016\/j.tox.2009.01.007","journal-title":"Toxicology"},{"key":"4411_CR39","doi-asserted-by":"crossref","unstructured":"Holsapple MP, Pitot HC, Cohen SH, Boobis AR, Klaunig JE, Pastoor T, Dellarco VL, Dragan YP. Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicological Sciences. 2006 Jan 1;89(1):51-6.","DOI":"10.1093\/toxsci\/kfj001"},{"key":"4411_CR40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1289\/ehp.9193247","volume":"93","author":"J Huff","year":"1991","unstructured":"Huff J, Cirvello J, Haseman J, Bucher J (1991) Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents. Environ Health Perspect 93:247\u2013270. https:\/\/doi.org\/10.1289\/ehp.9193247","journal-title":"Environ Health Perspect"},{"key":"4411_CR41","first-page":"161","volume-title":"IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 79, Some thyrotropic agents: Phenobarbital and its sodium salt","author":"IARC","year":"2001","unstructured":"IARC (2001) IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 79, Some thyrotropic agents: Phenobarbital and its sodium salt. IARCPress, Lyon, France, pp 161\u2013288"},{"key":"4411_CR42","unstructured":"IARC (2012) Chemical Agents and Related Occupations IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 100F. A review of human carcinogens. Part F: Chemical agents and related occupations \/ IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2009: Lyon, France)."},{"issue":"8","key":"4411_CR43","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1007\/s00204-020-02784-5","volume":"94","author":"MN Jacobs","year":"2020","unstructured":"Jacobs MN, Colacci A, Corvi R, Vaccari M, Aguila MC, Corvaro M, Delrue N, Desaulniers D, Ertych N, Jacobs A, Luijten M, Madia F, Nishikawa A, Ogawa K, Ohmori K, Paparella M, Sharma AK, Vasseur P (2020) Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens. Arch Toxicol 94(8):2899\u20132923. https:\/\/doi.org\/10.1007\/s00204-020-02784-5","journal-title":"Arch Toxicol"},{"issue":"4","key":"4411_CR44","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3390\/cells1041261","volume":"1","author":"L-I Kang","year":"2012","unstructured":"Kang L-I, Mars WM, Michalopoulos GK (2012) Signals and cells involved in regulating liver regeneration. Cells 1(4):1261\u20131292","journal-title":"Cells"},{"issue":"8","key":"4411_CR45","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1007\/s00204-020-02765-8","volume":"94","author":"EEJ Kasteel","year":"2020","unstructured":"Kasteel EEJ, Darney K, Kramer NI, Dorne JLCM, Lautz LS (2020) Human variability in isoform-specific UDP-glucuronosyltransferases: markers of acute and chronic exposure, polymorphisms and uncertainty factors. Arch Toxicol 94(8):2637\u20132661. https:\/\/doi.org\/10.1007\/s00204-020-02765-8","journal-title":"Arch Toxicol"},{"issue":"2","key":"4411_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/cells12020208","volume":"12","author":"M Kimura","year":"2023","unstructured":"Kimura M, Moteki H, Ogihara M (2023) Role of hepatocyte growth regulators in liver regeneration. Cells 12(2):208","journal-title":"Cells"},{"issue":"6","key":"4411_CR47","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1080\/713608372","volume":"33","author":"JE Klaunig","year":"2003","unstructured":"Klaunig JE, Babich MA, Baetcke KP, Cook JC, Corton JC, David RM, DeLuca JG, Lai DY, McKee RH, Peters JM, Roberts RA, Fenner-Crisp PA (2003) PPARalpha agonist-induced rodent tumors: modes of action and human relevance. Crit Rev Toxicol 33(6):655\u2013780. https:\/\/doi.org\/10.1080\/713608372","journal-title":"Crit Rev Toxicol"},{"issue":"1","key":"4411_CR48","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/toxsci\/kfaa017","volume":"175","author":"M Kondo","year":"2020","unstructured":"Kondo M, Kikumoto H, Osimitz TG, Cohen SM, Lake BG, Yamada T (2020) An evaluation of the human relevance of the liver tumors observed in female mice treated with permethrin based on mode of action. Toxicol Sci 175(1):50\u201363. https:\/\/doi.org\/10.1093\/toxsci\/kfaa017","journal-title":"Toxicol Sci"},{"issue":"1","key":"4411_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CEJ.0b013e32836014c8","volume":"23","author":"C La Vecchia","year":"2014","unstructured":"La Vecchia C, Negri E (2014) A review of epidemiological data on epilepsy, phenobarbital, and risk of liver cancer. Eur J Cancer Prev 23(1):1\u20137. https:\/\/doi.org\/10.1097\/CEJ.0b013e32836014c8","journal-title":"Eur J Cancer Prev"},{"issue":"8","key":"4411_CR50","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1080\/00498250903098184","volume":"39","author":"BG Lake","year":"2009","unstructured":"Lake BG (2009) Species differences in the hepatic effects of inducers of cyp2b and cyp4a subfamily forms: relationship to rodent liver tumour formation. Xenobiotica 39(8):582\u2013596. https:\/\/doi.org\/10.1080\/00498250903098184","journal-title":"Xenobiotica"},{"issue":"4","key":"4411_CR51","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1039\/c8tx00008e","volume":"7","author":"BG Lake","year":"2018","unstructured":"Lake BG (2018) Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators. Toxicol Res (Camb) 7(4):697\u2013717. https:\/\/doi.org\/10.1039\/c8tx00008e","journal-title":"Toxicol Res (Camb)"},{"key":"4411_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2020.152465","volume":"439","author":"BG Lake","year":"2020","unstructured":"Lake BG, Price RJ, Scott MP, Chatham LR, Vardy A, Osimitz TG (2020) Piperonyl butoxide: mode of action analysis for mouse liver tumour formation and human relevance. Toxicology 439:152465. https:\/\/doi.org\/10.1016\/j.tox.2020.152465","journal-title":"Toxicology"},{"key":"4411_CR53","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.toxrep.2017.10.007","volume":"4","author":"JL LaRocca","year":"2017","unstructured":"LaRocca JL, Rasoulpour RJ, Gollapudi BB, Eisenbrandt DL, Murphy LA, LeBaron MJ (2017) Integration of novel approaches demonstrates simultaneous metabolic inactivation and CAR-mediated hepatocarcinogenesis of a nitrification inhibitor. Toxicol Rep 4:586\u2013597. https:\/\/doi.org\/10.1016\/j.toxrep.2017.10.007","journal-title":"Toxicol Rep"},{"key":"4411_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2020.104789","volume":"118","author":"M Luijten","year":"2020","unstructured":"Luijten M, Corvi R, Mehta J, Corvaro M, Delrue N, Felter S, Haas B, Hewitt NJ, Hilton G, Holmes T, Jacobs MN, Jacobs A, Lamplmair F, Lewis D, Madia F, Manou I, Melching-Kollmuss S, Schorsch F, Sch\u00fctte K, Sewell F, Strupp C, van der Laan JW, Wolf DC, Wolterink G, Woutersen R, Zvonar Z, Heusinkveld H, Braakhuis H (2020) A comprehensive view on mechanistic approaches for cancer risk assessment of non-genotoxic agrochemicals. Regul Toxicol Pharmacol 118:104789. https:\/\/doi.org\/10.1016\/j.yrtph.2020.104789","journal-title":"Regul Toxicol Pharmacol"},{"issue":"19","key":"4411_CR55","doi-asserted-by":"publisher","first-page":"17277","DOI":"10.1074\/jbc.M300138200","volume":"278","author":"JM Maglich","year":"2003","unstructured":"Maglich JM, Parks DJ, Moore LB, Collins JL, Goodwin B, Billin AN, Stoltz CA, Kliewer SA, Lambert MH, Willson TM, Moore JT (2003) Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J Biol Chem 278(19):17277\u201317283. https:\/\/doi.org\/10.1074\/jbc.M300138200","journal-title":"J Biol Chem"},{"issue":"6","key":"4411_CR56","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/713608373","volume":"33","author":"ME Meek","year":"2003","unstructured":"Meek ME, Bucher JR, Cohen SM, Dellarco V, Hill RN, Lehman-McKeeman LD, Longfellow DG, Pastoor T, Seed J, Patton DE (2003) A framework for human relevance analysis of information on carcinogenic modes of action. Crit Rev Toxicol 33(6):591\u2013653. https:\/\/doi.org\/10.1080\/713608373","journal-title":"Crit Rev Toxicol"},{"issue":"1","key":"4411_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jat.2949","volume":"34","author":"ME Meek","year":"2014","unstructured":"Meek ME, Boobis A, Cote I, Dellarco V, Fotakis G, Munn S, Seed J, Vickers C (2014a) New developments in the evolution and application of the WHO\/IPCS framework on mode of action\/species concordance analysis. J Appl Toxicol 34(1):1\u201318. https:\/\/doi.org\/10.1002\/jat.2949","journal-title":"J Appl Toxicol"},{"issue":"6","key":"4411_CR58","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jat.2984","volume":"34","author":"ME Meek","year":"2014","unstructured":"Meek ME, Palermo CM, Bachman AN, North CM, Jeffrey Lewis R (2014b) Mode of action human relevance (species concordance) framework: evolution of the Bradford Hill considerations and comparative analysis of weight of evidence. J Appl Toxicol 34(6):595\u2013606. https:\/\/doi.org\/10.1002\/jat.2984","journal-title":"J Appl Toxicol"},{"issue":"1","key":"4411_CR59","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1006\/rtph.1993.1048","volume":"18","author":"A Monro","year":"1993","unstructured":"Monro A (1993) The paradoxical lack of interspecies correlation between plasma concentrations and chemical carcinogenicity. Regul Toxicol Pharmacol 18(1):115\u2013135. https:\/\/doi.org\/10.1006\/rtph.1993.1048","journal-title":"Regul Toxicol Pharmacol"},{"issue":"11","key":"4411_CR60","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1080\/17425255.2017.1391214","volume":"13","author":"M Neary","year":"2017","unstructured":"Neary M, Owen A (2017) Pharmacogenetic considerations for HIV treatment in different ethnicities: an update. Expert Opin Drug Metab Toxicol 13(11):1169\u20131181. https:\/\/doi.org\/10.1080\/17425255.2017.1391214","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"4411_CR61","doi-asserted-by":"publisher","DOI":"10.1787\/e1f1244b-en","volume-title":"Guidance document on the validation and international acceptance of new or updated test methods for hazard assessment, OECD Series on Testing and Assessment, No. 34","author":"OECD","year":"2005","unstructured":"OECD (2005) Guidance document on the validation and international acceptance of new or updated test methods for hazard assessment, OECD Series on Testing and Assessment, No. 34. OECD Publishing, Paris. https:\/\/doi.org\/10.1787\/e1f1244b-en"},{"issue":"6","key":"4411_CR62","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2131\/jts.42.773","volume":"42","author":"Y Okuda","year":"2017","unstructured":"Okuda Y, Kushida M, Kikumoto H, Nakamura Y, Higuchi H, Kawamura S, Cohen SM, Lake BG, Yamada T (2017) Evaluation of the human relevance of the constitutive androstane receptor-mediated mode of action for rat hepatocellular tumor formation by the synthetic pyrethroid momfluorothrin. J Toxicol Sci 42(6):773\u2013788. https:\/\/doi.org\/10.2131\/jts.42.773","journal-title":"J Toxicol Sci"},{"issue":"Suppl 1","key":"4411_CR63","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1093\/toxsci\/kfq338","volume":"120","author":"CJ Omiecinski","year":"2011","unstructured":"Omiecinski CJ, Vanden Heuvel JP, Perdew GH, Peters JM (2011) Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. Toxicol Sci 120(Suppl 1):S49\u2013S75. https:\/\/doi.org\/10.1093\/toxsci\/kfq338","journal-title":"Toxicol Sci"},{"issue":"6","key":"4411_CR64","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/10408440902914014","volume":"39","author":"TG Osimitz","year":"2009","unstructured":"Osimitz TG, Lake BG (2009) Mode-of-action analysis for induction of rat liver tumors by pyrethrins: relevance to human cancer risk. Crit Rev Toxicol 39(6):501\u2013511. https:\/\/doi.org\/10.1080\/10408440902914014","journal-title":"Crit Rev Toxicol"},{"key":"4411_CR65","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.fct.2013.08.020","volume":"60","author":"TG Osimitz","year":"2013","unstructured":"Osimitz TG, Droege W, Boobis AR, Lake BG (2013) Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans. Food Chem Toxicol 60:550\u2013562. https:\/\/doi.org\/10.1016\/j.fct.2013.08.020","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"4411_CR66","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.taap.2004.01.010","volume":"199","author":"A Parkinson","year":"2004","unstructured":"Parkinson A, Mudra DR, Johnson C, Dwyer A, Carroll KM (2004) The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol Appl Pharmacol 199(3):193\u2013209. https:\/\/doi.org\/10.1016\/j.taap.2004.01.010","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"4411_CR67","first-page":"1143","volume":"51","author":"W Parzefall","year":"1991","unstructured":"Parzefall W, Erber E, Sedivy R, Schulte-Hermann R (1991) Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters. Cancer Res 51(4):1143\u20131147","journal-title":"Cancer Res"},{"issue":"3","key":"4411_CR68","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/carcin\/22.3.519","volume":"22","author":"W Parzefall","year":"2001","unstructured":"Parzefall W, Berger W, Kainzbauer E, Teufelhofer O, Schulte-Hermann R, Thurman RG (2001) Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes. Carcinogenesis 22(3):519\u2013523. https:\/\/doi.org\/10.1093\/carcin\/22.3.519","journal-title":"Carcinogenesis"},{"issue":"2","key":"4411_CR69","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/toxsci\/kfx281","volume":"162","author":"RC Peffer","year":"2018","unstructured":"Peffer RC, Cowie DE, Currie RA, Minnema DJ (2018a) Sedaxane- use of nuclear receptor transactivation assays, toxicogenomics, and toxicokinetics as part of a mode of action framework for rodent liver tumors. Toxicol Sci 162(2):582\u2013598. https:\/\/doi.org\/10.1093\/toxsci\/kfx281","journal-title":"Toxicol Sci"},{"key":"4411_CR70","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.yrtph.2018.04.001","volume":"96","author":"RC Peffer","year":"2018","unstructured":"Peffer RC, LeBaron MJ, Battalora M, Bomann WH, Werner C, Aggarwal M, Rowe RR, Tinwell H (2018b) Minimum datasets to establish a CAR-mediated mode of action for rodent liver tumors. Regul Toxicol Pharmacol 96:106\u2013120. https:\/\/doi.org\/10.1016\/j.yrtph.2018.04.001","journal-title":"Regul Toxicol Pharmacol"},{"issue":"2","key":"4411_CR71","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1006\/taap.1998.8413","volume":"150","author":"CE Perrone","year":"1998","unstructured":"Perrone CE, Shao L, Williams GM (1998) Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty Acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes. Toxicol Appl Pharmacol 150(2):277\u2013286. https:\/\/doi.org\/10.1006\/taap.1998.8413","journal-title":"Toxicol Appl Pharmacol"},{"issue":"9","key":"4411_CR72","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1093\/carcin\/19.9.1521","volume":"19","author":"NJ Plant","year":"1998","unstructured":"Plant NJ, Horley NJ, Dickins M, Hasmall S, Elcombe CR, Bell DR (1998) The coordinate regulation of DNA synthesis and suppression of apoptosis is differentially regulated by the liver growth agents, phenobarbital and methylclofenapate. Carcinogenesis 19(9):1521\u20131527. https:\/\/doi.org\/10.1093\/carcin\/19.9.1521","journal-title":"Carcinogenesis"},{"key":"4411_CR73","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.toxrep.2019.09.010","volume":"6","author":"S Plummer","year":"2019","unstructured":"Plummer S, Beaumont B, Wallace S, Ball G, Wright J, McInnes L, Currie R, Peffer R, Cowie D (2019) Cross-species comparison of CAR-mediated procarcinogenic key events in a 3D liver microtissue model. Toxicol Rep 6:998\u20131005. https:\/\/doi.org\/10.1016\/j.toxrep.2019.09.010","journal-title":"Toxicol Rep"},{"key":"#cr-split#-4411_CR74.1","unstructured":"European Commission (2009) Regulation"},{"key":"#cr-split#-4411_CR74.2","unstructured":"(EC) No 1107\/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79\/117\/EEC and 91\/414\/EEC. Special edition in Croatian: Chapter 03 Volume 061 P. 52 - 101. (Current consolidated version: 21\/11\/2022). Off J Eur Union http:\/\/data.europa.eu\/eli\/reg\/2009\/1107\/oj."},{"issue":"9","key":"4411_CR75","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/10408440701524949","volume":"37","author":"LR Rhomberg","year":"2007","unstructured":"Rhomberg LR, Baetcke K, Blancato J, Bus J, Cohen S, Conolly R, Dixit R, Doe J, Ekelman K, Fenner-Crisp P, Harvey P, Hattis D, Jacobs A, Jacobson-Kram D, Lewandowski T, Liteplo R, Pelkonen O, Rice J, Somers D, Turturro A, West W, Olin S (2007) Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection. Crit Rev Toxicol 37(9):729\u2013837. https:\/\/doi.org\/10.1080\/10408440701524949. (PMID: 17957539)","journal-title":"Crit Rev Toxicol"},{"issue":"4","key":"4411_CR76","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/17425255.2020.1746268","volume":"16","author":"R Shizu","year":"2020","unstructured":"Shizu R, Yoshinari K (2020) Nuclear receptor CAR-mediated liver cancer and its species differences. Expert Opin Drug Metab Toxicol 16(4):343\u2013351. https:\/\/doi.org\/10.1080\/17425255.2020.1746268","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"4411_CR77","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/toxsci\/kfad129","volume":"198","author":"R Shizu","year":"2024","unstructured":"Shizu R, Makida N, Sobe K, Ishimura M, Takeshita A, Hosaka T, Kanno Y, Sasaki T, Yoshinari K (2024) Interaction with YAP underlies the species differences between humans and rodents in CAR-dependent hepatocyte proliferation. Toxicol Sci 198(1):101\u2013112. https:\/\/doi.org\/10.1093\/toxsci\/kfad129","journal-title":"Toxicol Sci"},{"key":"4411_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2397847318772839","volume":"2","author":"CJ Smith","year":"2018","unstructured":"Smith CJ, Perfetti TA (2018) The \u201cfalse-positive\u201d conundrum in the NTP 2-year rodent cancer study database. Toxicol Res Appl 2:1\u201313. https:\/\/doi.org\/10.1177\/2397847318772839","journal-title":"Toxicol Res Appl"},{"issue":"1","key":"4411_CR79","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1039\/C2TX20051A","volume":"2","author":"VY Soldatow","year":"2013","unstructured":"Soldatow VY, LeCluyse EL, Griffith LG, Rusyn I (2013) In vitro models for liver toxicity testing. Toxicol Res (Camb) 2(1):23\u201339. https:\/\/doi.org\/10.1039\/C2TX20051A","journal-title":"Toxicol Res (Camb)"},{"key":"4411_CR80","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.tiv.2016.08.006","volume":"36","author":"V Soldatow","year":"2016","unstructured":"Soldatow V, Peffer RC, Trask OJ, Cowie DE, Andersen ME, LeCluyse E, Deisenroth C (2016) Development of an in vitro high content imaging assay for quantitative assessment of CAR-dependent mouse, rat, and human primary hepatocyte proliferation. Toxicol in Vitro 36:224\u2013237. https:\/\/doi.org\/10.1016\/j.tiv.2016.08.006","journal-title":"Toxicol in Vitro"},{"issue":"2","key":"4411_CR81","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1006\/rtph.2001.1493","volume":"34","author":"C Sonich-Mullin","year":"2001","unstructured":"Sonich-Mullin C, Fielder R, Wiltse J, Baetcke K, Dempsey J, Fenner-Crisp P, Grant D, Hartley M, Knaap A, Kroese D, Mangelsdorf I, Meek E, Rice JM, Younes M (2001) IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul Toxicol Pharmacol 34(2):146\u2013152. https:\/\/doi.org\/10.1006\/rtph.2001.1493","journal-title":"Regul Toxicol Pharmacol"},{"issue":"6","key":"4411_CR82","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1007\/s00415-020-10379-4","volume":"286","author":"J Stritzelberger","year":"2021","unstructured":"Stritzelberger J, Lang JD, Mueller TM, Reindl C, Westermayer V, Kostev K, Hamer HM (2021) Anti-seizure medication is not associated with an increased risk to develop cancer in epilepsy patients. J Neurol 286(6):2185\u20132191. https:\/\/doi.org\/10.1007\/s00415-020-10379-4","journal-title":"J Neurol"},{"key":"4411_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2020.104758","volume":"117","author":"C Strupp","year":"2020","unstructured":"Strupp C, Quesnot N, Richert L, Moore J, Bomann WH, Singh P (2020) Weight of evidence and human relevance evaluation of the benfluralin mode of action in rodents (Part I): liver carcinogenesis. Regul Toxicol Pharmacol 117:104758. https:\/\/doi.org\/10.1016\/j.yrtph.2020.104758","journal-title":"Regul Toxicol Pharmacol"},{"issue":"17","key":"4411_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713246","volume":"24","author":"C Strupp","year":"2023","unstructured":"Strupp C, Corvaro M, Cohen SM, Corton JC, Ogawa K, Richert L, Jacobs MN (2023) Increased cell proliferation as a key event in chemical carcinogenesis: application in an integrated approach for the testing and assessment of non-genotoxic carcinogenesis. Int J Mol Sci 24(17):13246. https:\/\/doi.org\/10.3390\/ijms241713246","journal-title":"Int J Mol Sci"},{"key":"4411_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s42826-019-0032-y","volume":"36","author":"C Tateno","year":"2020","unstructured":"Tateno C, Kojima Y (2020) Characterization and applications of chimeric mice with humanized livers for preclinical drug development. Lab Anim Res 36:2. https:\/\/doi.org\/10.1186\/s42826-019-0032-y","journal-title":"Lab Anim Res"},{"key":"4411_CR86","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/0192623314544378","volume":"43","author":"C Tateno","year":"2015","unstructured":"Tateno C, Yamamoto T, Utoh R, Yamasaki C, Ishida Y, Myoken Y, Oofusa K, Okada M, Tsutsui N, Yoshizato K (2015) Chimeric mice with hepatocyte-humanized liver as an appropriate model to study human peroxisome proliferator\u2013activated receptor-\u03b1. Toxicol Pathol 43:233\u2013248. https:\/\/doi.org\/10.1177\/0192623314544378","journal-title":"Toxicol Pathol"},{"key":"4411_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2020.104800","volume":"119","author":"C Terry","year":"2021","unstructured":"Terry C, Yan Z, Corvaro M, Gehen SC (2021) A retrospective study on EU harmonised classifications for carcinogenicity to guide future research. Regul Toxicol Pharmacol 119:104800. https:\/\/doi.org\/10.1016\/j.yrtph.2020.104800","journal-title":"Regul Toxicol Pharmacol"},{"issue":"5","key":"4411_CR88","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/10408444.2022.2115875","volume":"52","author":"P van Kesteren","year":"2022","unstructured":"van Kesteren P, Pronk M, Heusinkveld H, Luijten M, Hakkert B (2022) Letter to the editor regarding the review article by Yamada et al. (2021) titled \u201cCritical evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR).\u201d Crit Rev Toxicol 52(5):397\u2013398. https:\/\/doi.org\/10.1080\/10408444.2022.2115875","journal-title":"Crit Rev Toxicol"},{"issue":"1\u20132","key":"4411_CR89","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0163-7258(96)00067-8","volume":"71","author":"J Whysner","year":"1996","unstructured":"Whysner J, Ross PM, Williams GM (1996) Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacol Ther 71(1\u20132):153\u2013191. https:\/\/doi.org\/10.1016\/0163-7258(96)00067-8","journal-title":"Pharmacol Ther"},{"key":"4411_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2019.152282","volume":"426","author":"C Wiemann","year":"2019","unstructured":"Wiemann C, Goettel M, Vardy A, Elcombe BM, Elcombe CR, Chatham LR, Wang H, Li L, Buesen R, Honarvar N, Truemann S, Marxfeld H, Groeters S, Lake BG (2019) Metazachlor: mode of action analysis for rat liver tumour formation and human relevance. Toxicology 426:152282. https:\/\/doi.org\/10.1016\/j.tox.2019.152282","journal-title":"Toxicology"},{"key":"4411_CR91","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.yrtph.2019.01.021","volume":"103","author":"DC Wolf","year":"2019","unstructured":"Wolf DC, Cohen SM, Boobis AR, Dellarco VL, Fenner-Crisp PA, Moretto A, Pastoor TP, Schoeny RS, Seed JG, Doe JE (2019) Chemical carcinogenicity revisited 1: a unified theory of carcinogenicity based on contemporary knowledge. Regul Toxicol Pharmacol 103:86\u201392. https:\/\/doi.org\/10.1016\/j.yrtph.2019.01.021","journal-title":"Regul Toxicol Pharmacol"},{"issue":"6","key":"4411_CR92","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1177\/0192623315576005","volume":"43","author":"CE Wood","year":"2015","unstructured":"Wood CE, Hukkanen RR, Sura R, Jacobson-Kram D, Nolte T, Odin M, Cohen SM (2015) Scientific and regulatory policy committee (SRPC) review: interpretation and use of cell proliferation data in cancer risk assessment. Toxicol Pathol 43(6):760\u2013775. https:\/\/doi.org\/10.1177\/0192623315576005","journal-title":"Toxicol Pathol"},{"issue":"4","key":"4411_CR93","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1293\/tox.2021-0027","volume":"34","author":"T Yamada","year":"2021","unstructured":"Yamada T (2021) Application of humanized mice to toxicology studies: evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR). J Toxicol Pathol 34(4):283\u2013297. https:\/\/doi.org\/10.1293\/tox.2021-0027","journal-title":"J Toxicol Pathol"},{"issue":"1","key":"4411_CR94","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/toxsci\/kfu173","volume":"142","author":"T Yamada","year":"2014","unstructured":"Yamada T, Okuda Y, Kushida M, Sumida K, Takeuchi H, Nagahori H, Fukuda T, Lake BG, Cohen SM, Kawamura S (2014) Human hepatocytes support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver. Toxicol Sci 142(1):137\u2013157. https:\/\/doi.org\/10.1093\/toxsci\/kfu173","journal-title":"Toxicol Sci"},{"issue":"4","key":"4411_CR95","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1039\/c4tx00217b","volume":"4","author":"T Yamada","year":"2015","unstructured":"Yamada T, Kikumoto H, Lake BG, Kawamura S (2015) Lack of effect of metofluthrin and sodium phenobarbital on replicative DNA synthesis and Ki-67 mRNA expression in cultured human hepatocytes. Toxicol Res 4(4):901\u2013913. https:\/\/doi.org\/10.1039\/c4tx00217b","journal-title":"Toxicol Res"},{"issue":"5","key":"4411_CR96","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/10408444.2021.1939654","volume":"51","author":"T Yamada","year":"2021","unstructured":"Yamada T, Cohen SM, Lake BG (2021) Critical evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR). Crit Rev Toxicol 51(5):373\u2013394. https:\/\/doi.org\/10.1080\/10408444.2021.1939654","journal-title":"Crit Rev Toxicol"},{"issue":"5","key":"4411_CR97","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/10408444.2022.2101915","volume":"52","author":"T Yamada","year":"2022","unstructured":"Yamada T, Cohen SM, Lake BG (2022) Response to Letter to the Editor from Drs. van Kesteren, Pronk, Heusinkveld, Luijten and Hakkert concerning Yamada et al. (2021): Critical evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR). Crit. Rev. Toxicol. Vol. 51: 373-394. Crit Rev Toxicol 52(5):399\u2013402. https:\/\/doi.org\/10.1080\/10408444.2022.2101915","journal-title":"Crit Rev Toxicol"},{"issue":"5","key":"4411_CR98","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1080\/10408444.2025.2513332","volume":"55","author":"T Yamada","year":"2025","unstructured":"Yamada T, Cohen SM, Lake BG (2025) The modes of action for rodent liver tumor formation by actiavtors of the constitutive androstane receptor (CAR) and the peroxisome proliferator-activated receptor alpha (PPAR\u03b1) are not relevant to human cancer risk: an updated critcial evaluation. Crit Rev Toxicol 55(5):549\u2013586. https:\/\/doi.org\/10.1080\/10408444.2025.2513332","journal-title":"Crit Rev Toxicol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04411-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-026-04411-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04411-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:35:17Z","timestamp":1784313317000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-026-04411-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":99,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4411"],"URL":"https:\/\/doi.org\/10.1007\/s00204-026-04411-1","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CS, DEC, HT, JT, MG, MES and MG are employed by companies developing and producing plant protection products. TY was employed until the end of March 2025 by Sumitomo Chemical Company Ltd. CS is a member of the OECD working group on nongenotoxic carcinogenicity. SMC and BGL consult for the Sumitomo Chemical Co Ltd., provider of the Laboratory 2 data for this publication. The authors declare that they have no conflicts of interest associated with this work.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}